Cell-and receptor-specific regulation of cell migration by Gi/oα-proteins remains unknown in prostate cancer cells. In the present study, oxytocin (OXT) receptor (OXTR) was detected at the protein level in total cell lysates from C81 (an androgen-independent subline of LNCaP), DU145 and PC3 prostate cancer cells, but not in immortalized normal prostate luminal epithelial cells (RWPE1), and OXT induced migration of PC3 cells. This effect of OXT has been shown to be mediated by Gi/oα-dependent signaling. Accordingly, OXT inhibited forskolin-induced luciferase activity in PC3 cells that were transfected with a luciferase reporter for cAMP activity. Although mRNAs for all three Giα isoforms were present in PC3 cells, Giα2 was the most abundant isoform that was detected at the protein level. Pertussis toxin (PTx) inhibited the OXT-induced migration of PC3 cells. Ectopic expression of the PTx-resistant Giα2-C352G, but not wild type Giα2, abolished this effect of PTx on OXT-induced cell migration. The Giα2-targeting siRNA was shown to specifically reduce Giα2 mRNA and protein in prostate cancer cells. The Giα2-targeting siRNA eliminated OXT-induced migration of PC3 cells. These data suggest that Giα2 plays an important role in the effects of OXT on PC3 cell migration. The Giα2-targeting siRNA also inhibited EGF-induced migration of PC3 and DU145 cells. Expression of the siRNA-resistant Giα2, but not wild type Giα2, restored the effects of EGF in PC3 cells transfected with the Giα2-targeting siRNA. In conclusion, Giα2 plays an essential role in OXT and EGF signaling to induce prostate cancer cell migration.
Introduction
Heterotrimeric guanosine phosphate-binding proteins (G-proteins) are composed of α, β, and γ subunits. Gβ and Gγ form a dimer that is associated with inactive Gα (1) (2) (3) . Activated Gprotein-coupled receptor (GPCR) catalyzes the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) on Gα, resulting in the dissociation of Gβγ from the activated Gα (4) . Gα subunits have intrinsic GTPase activities that hydrolyze the GTP into GDP and terminate the G-protein coupled signaling (4) . The GTP hydrolysis is accelerated by the regulator of G-protein signaling protein (RGS) (4) . There are 23 Gα isoforms that are divided into four subfamilies, including Gs, Gi/o, Gq/11, and G12/13 (4) . Activation of Gi/o-proteins inhibits adenylyl cyclases and reduces intracellular cAMP levels (5) . Giα1, Giα2, Giα3, GoαA, and GoαB are Gi/oα-proteins that are ubiquitously expressed and sensitive to pertussis toxin (PTx) (4) . GoαA and GoαB are derived from splice variants of the Goα gene that is preferentially expressed in the central nervous system (6, 7) . PTx catalyzes ADP ribosylation of the cystine (C) residues at C-terminal ends of the Gi/oα-proteins, which results in the uncoupling of these G-proteins from their cognate GPCRs (8) . Substitution of the cystine for glycine eliminates the PTx ADP-ribosylation site, however, the resulting Gi/oα mutants have been shown to retain abilities to couple to GPCRs and induce biological responses (9) .
Prostate cancer development and progression is androgen dependent, and androgen deprivation therapy is currently among the regular procedures to treat metastatic prostate cancer (10) (11) (12) . However, disease relapse often ensues from androgen ablation, producing castration resistant prostate cancer (CRPC) that results in increased malignancy and poor prognosis (10, 12, 13) . Emerging evidence has suggested that GPCR signaling plays an important role in prostate cancer progression (14) . Activation of G12/13-proteins has been shown to increase prostate cancer invasion via activation of RhoA family of small G-proteins (15) . Both Gs-and Gq-dependent signaling induce the transactivation of androgen receptor in prostate cancer cells (16, 17) , which has been shown to facilitate transition of primary prostate tumor cells to the androgen independent stage (18) . Expression of RGS2, a negative regulator of Gi-as well as Gq-dependent signaling, is significantly reduced in human prostate cancer specimens when compared with the adjacent normal or hyperplastic prostate tissues (19) . Therefore, signaling of GPCRs, either Gi-or Gq-coupled, is potentially amplified in primary prostate tumors. PTx has been shown to inhibit the growth of PC3 prostate cancer cells (20) . PTx sensitivity indicates the involvement of Gi/o-dependent signaling (8) . Nevertheless, PTx treatment cannot distinguish receptor-and cell-specific functions of Gi/oα isoforms. Activated CXCR3 receptor induces migration of T lymphocytes via a Giα2-dependent mechanism, which is counteracted by Giα3 (21) . There is no evidence suggesting the presence of isoform-specific functions of heterotrimeric G-proteins in prostate cancer cells.
Oxytocin (OXT) is a peptide hormone that regulates normal prostate functions. OXT treatment has been shown to increase epithelial cell growth, 5α-reductase activity, and contractility in normal prostate (22) (23) (24) . However, the information is very limited about the effect of OXT on prostate cancer progression. OXT receptor (OXTR) has been detected in tissues from hyperplastic and neoplastic prostate (25) , but not in the epithelium of normal human prostate (26) . Recently, OXTR has been shown to be the primary target of OXT in androgen-independent prostate cancer cell lines (DU145 and PC3) (27) . OXTR is a GPCR that promiscuously couples to multiple G-proteins including Gq and Gi (28, 29) . Activated OXTR induces migration of PC3 cells via a PTx-sensitive mechanism (27) . In the present study, OXTR protein was detected in prostate cancer cell lines (C81, DU145, and PC3), but not in the 
Materials and Methods

Reagents
Human OXT, pertussis toxin, bovine serum albumin (BSA), rabbit anti-OXTR antibody, anti-α-tubulin antibody, and mouse anti-β-actin antibody were obtained from Sigma (St. Louis, MO). Mouse monoclonal anti-Giα1 antibody, rabbit anti-Giα2, and anti-Giα3 antibodies were obtained from EMD-Millipore (Temecula, CA)Total lysates from E. coli expressing recombinant rat Giα1, Giα2, and Giα3 proteins and an additional rabbit anti-human Giα2 antibody, were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Steady glow luciferase reagent, M-MLV reverse transcriptase, T4-ligase, GoTaq qPCR master mix, and oligo dT primer were purchased from Promega (Madison, WI). Taq polymerase was purchased from Lucigen (Middleton, WI). Phusion high-fidelity PCR kit and restriction enzymes were purchased from New England Biolabs (Ipswich, MA). DNA primers were purchased from IDT (San Jose, CA). were added drop by drop into 6-well plates. The transfection media were replaced with the regular culture media (2 ml/well) the next day. RNA samples were harvested 72 h after transfection. Protein samples were collected at 72 and 96 h after transfection.
Transfection of plasmid DNAs
MEM (200 µl/well) containing plasmid DNA (2 μg/well) was mixed with lipofectamine 2000 (6 μl/well) and incubated for 30 min. Plasmid DNA mixtures were added drop by drop into 6-well plates. Transfected PC3 cells were cultured for up to 48 h.
Generation of PC3 cell lines ectopically expressing wild type and the siRNA-resistant Giα2
Transfected PC3 cells were placed in 100 mm 2 culture dishes and were grown in culture medium supplemented with 600 µg/ml of G418. A week later, cells were maintained in culture medium supplemented with 200 µg/ml of G418. Single colonies were picked and grown in 6-well plates. Expression of Giα2 was verified in total cell lysates by Western blot analysis.
Western blot analysis
PC3 cell membranes were prepared as described previously (30) . Membrane proteins (50 μg) or total cell proteins (100 μg) were separated on 10% SDS-PAGE gels and transferred onto PVDF membranes and analyzed for Western blotting as described previously (27) . Giα1-3 proteins were detected with isoform-specific antibodies (1:1000 dilution). OXTR was detected in total cell lysates with anti-OXTR antibody (1:1000 dilution). 30 µg of total cell proteins were used for detection of β-actin with a mouse monoclonal antibody (1:10,000 dilution). 
RNA extraction, reverse transcription (RT)-PCR and quantitative real-time PCR
Total RNAs were extracted from cells using Trizol and the RNA content was determined at 260 nm with a UV spectrophotometer. First strand cDNA was synthesized from 2 μg of total RNA as described previously (27) . No-RT control samples were prepared in parallel by replacing reverse transcriptase with RNase.
Expression of Giα1, Giα2, Giα3, GoαA, GoαB and L19 genes was detected with the PCR procedure described previously (27) . Specific primers are listed in Table 1 . PCR products were separated by electrophoresis on 1.5% agarose gels containing ethidium bromide. DNA bands were visualized under UV light and images were documented using the Bio-Rad gel imager (Hercules, CA).
For quantitative real-time PCR, cDNA samples (1 μl) were mixed with 0.2 μM primers and 2X GoTaq qPCR master mix in a final volume of 25 μl in a 96-well PCR plate. PCR detection was performed in an iCycler thermal cycler (Bio-Rad) with procedures described previously (27) .
Melting curves were examined for the quality of PCR amplification of each sample.
Calculations were performed using the ΔΔCt method (27) .
Cloning Giα1 and Giα3 genes from PC3 and DU145 cell lines
Open reading frames of Giα1 and Giα3 genes were amplified with the Phusion highfidelity PCR kit. The shared forward primer was, GCT TGG TAC CAT GGG CTG CAC GTT GAG CGC C. The reverse primer for Giα1 was, TAG ACT CGA GAT GCA TTT TAC CAT GAA CTG CAA. The reverse primer for Giα3 was, GCT TGG TAC CAT GGG CTG CAC GTT GAG CGC C. The PCR procedure was programmed as following: 94°C for 2 min, 30 cycles of the following steps: denaturation at 94°C for 30 seconds, annealing at 60°C for 20 seconds, and extension at 72°C for 1 minute. A final extension of 10 minutes was followed up after the cycles were completed. Purified PCR products were digested with Kpn I and Xho I and ligated into pcDNA3.1 plasmid. After transformation into XL1-Blue competent cells (Stratagene), five E .Coli colonies containing Giα1-or Giα3-expressing plasmid were grown overnight in LB broth supplemented with ampicillin. Plasmids were harvested with QIAprep spin miniprep kit (Qiagen) and sequenced from both ends with the cloning primers.
Luciferase reporter assay
The PC3 cells were harvested from the 6-well plates 24 h after transfection with the 
Cell migration assay
In Vitro cell migration assay was performed using 24-well transwell inserts (8 µm) as described previously (27) . Briefly, cells were harvested and centrifuged at 500 ×g for 10 min at room temperature. The pellets were resuspended into MEM supplemented with 0.2% BSA at a cell density of 3 × 10 5 cells/ml. Transwell inserts were treated with rat tail collagen (50 µg/ml) as described previously (27) . Chemoattractant solutions were made by diluting OXT (100 nM) or EGF (3 ng/ml) into MEM supplemented with 0.2% BSA. MEM containing 0.2% BSA served as a control medium. Aliquots of 100 µl cell suspension were loaded into transwell inserts and 
placed into 24-well plates that contained control and chemoattractant solutions (300 µl/well).
The plates were incubated at 37°C for 5 h. Cells inside the transwell inserts were removed by cotton swabs. The cleaned inserts were fixed in 4% paraformaldehyde (pH 7.5). Cells on the outside of the transwell insert membranes were stained using HEMA 3 staining kit (Fisher Scientific Inc, TX). The number of stained cells was counted as described previously (27) .
Results were expressed as migration index defined as: the average number of cells per field for test substance/the average number of cells per field for the medium control.
Statistical analysis
Data from multiple independent experiments (n=3-5) are expressed as Mean ± SEM.
ANOVA and Duncan's modified multiple range test were used to examine significance between multiple treatments. 
Results
OXT activates the Gi/oα-dependent pathway and induces PC3 cell migration
Expression of OXTR is elevated at the mRNA levels in androgen-independent DU145 and PC3 prostate cancer cell lines, compared with normal prostate epithelial cells (27) . In the present study, OXTR protein (~70 kDa) was detected in total cell lysates of DU145, PC3 and the androgen-independent subline of LNCaP (C81) prostate cancer cell lines, but not in the cell lysates of immortalized human prostate luminal epithelial cell line (RWPE1) (Fig. 1A) .
Immortalized pregnant human myometrial smooth muscle cell line (PHM1-41) expresses endogenous OXTR and was used as a positive control (Fig. 1A) .
OXT (100 nM) and EGF (3 ng/ml) induced PC3 cell migration (Fig. 1B) . This effect of OXT has been shown to be sensitive to PTx pretreatment, suggesting the involvement of Gi/oα-proteins (27) . Inhibiting cAMP accumulation is the canonical function of Gi/oα-proteins. PC3 cells were transfected with the pADneo2 C6-BGL plasmid containing a cAMP-responsive luciferase reporter. Forskolin (5 µM) induced a three-fold increase in luciferase activities in the transfected PC3 cells. Treatment with OXT caused a dose-dependent inhibition of forskolinstimulated luciferase activity (Fig. 1C) , which supports the involvement of Gi/oα in OXTR signaling in PC3 cells.
Giα2 is important for the OXT-induced migration of PC3 cells
Expression of Gi/oα isoforms was detected by RT-PCR with specific primers listed in Table 1 . Giα1, Giα2, and Giα3 were the predominant Gi/oα family members that are expressed at the mRNA levels in PC3 cells (data not shown). Because G-proteins are enriched in the cell membranes (5), the membrane fractions were prepared from PC3 cells to determine the expression of Giα1-3 proteins. Total lysates (100 ng) of E. coli expressing recombinant rat Giα1-3 proteins were used as positive controls. As shown in Fig. 2A , specific antibodies for Giα1-3 proteins were able to detect respective recombinant proteins. Giα2 was the only Giα family member that was detected in PC3 total cell lysates and membrane fractions (Fig. 2A) . In comparison, trace levesl of Giα3 protein were detected in only membrane fraction while Giα1 was undetectable in both total cell lysates and membrane fractions ( Fig. 2A) . Control and Giα2-targeting siRNAs were transfected into PC3 cells. RNA samples were harvested 72 h after transfection. Total cell proteins were harvested at 72 and 96 h after transfection. As shown in Fig. 3A , Giα2 mRNAs were the least abundant among the three Giα isoforms in PC3 cell line. Control siRNA did not affect mRNA levels of Giα1-3 in these cells.
The Giα2-targeting siRNA specifically reduced Giα2 mRNAs by 96% in this cell line (Fig. 3A) .
This Giα2-targeting siRNA caused a significant reduction (~75%) in Giα2 protein levels in PC3 cells at 72 and 96 h after transfection (Fig. 3B ).
OXT and EGF induced cell migration in the PC3 cells that were pretreated with control siRNA (Fig. 3C) . On the other hand, these effects of OXT and EGF were completely eliminated in the PC3 cells treated with the Giα2-targeting siRNA (Fig. 3C) . Inhibition of EGF-induced cell migration by the Giα2-targeting siRNA was unexpected. To further examine whether Giα2 has a specific role in the EGF-induced cell migration, PC3 stable cell lines were generated to ectopically express wild type Giα2 and the siRNA-resistant Giα2 genes (Fig. 4A) . The Giα2-targeting siRNA completely eliminated EGF-induced cell migration in the PC3 cells that ectopically expresses wild type Giα2 (Fig. 4A) . However, the Giα2-targeting siRNA failed to inhibit effects of EGF on migration of PC3 cells that expressed the siRNA-resistant Giα2 gene (Fig. 4A) . These data clearly support a critical role of Giα2 in EGF effects on cell migration.
We have previously shown that EGF induces migration of DU145 prostate cancer cells while these cells are not responsive to OXT effects on cell migration (27) . The Giα2-targeting siRNA, which caused a 93% reduction of Giα2 protein levels, blocked EGF-induced cell migration in DU145 cells (Fig. 4B) . 
Discussion
OXT is a peptide hormone that regulates normal prostate functions (22) (23) (24) . However, the information is very limited on the effects of OXT on prostate cancer progression. In the present study, OXTR protein was detected only in prostate cancer cell lines, although OXTR mRNA is expressed in normal and prostate cancer cell lines (27) . OXTR was also detected in the PHM1-41 cell lines that express endogenous OXTR (31) . These data indicate that expression of OXTR is amplified in prostate cancer cells. Immunohistochemistry staining for OXTR has shown that expression of OXTR is negative in normal human prostate epithelium (26) . However, OXTR has been shown to be expressed in hyperplastic as well as neoplastic prostate epithelium and to be increased in the neoplastic tissues when compared with the hyperplastic tissues (25) .
The expression profile of OXTR in normal and prostate cancer cell lines reflects its expression in human prostate in normal and disease states. Bioinformatic mining of Oncomine microarray database (www.oncomine.org) has shown that expression of OXTR is significantly increased in metastatic prostate cancer specimens when compared with normal prostate specimens (32) .
OXTR couples to multiple G-proteins including Gq and Gi. In turn, these G-proteins may convey OXT signaling to different intracellular pathways leading to distinct cellular functions (33) . Activated OXTR has been shown to induce migration of PC3 cells (27) . This effect of OXT is sensitive to PTx pretreatment, indicating the involvement of Gi/o-dependent signaling (27) . Inhibition of the intracellular cAMP accumulation is the canonical function of activated Gi/o-proteins (5). By employing a luciferase reporter assay to monitor changes in intracellular cAMP levels, we show that OXT caused a dose-dependent inhibition of forskolininduced luciferase activity. Hence, OXT activates Gi/o-dependent pathways in PC3 cells. 
OXTR has been shown to couple to Giα3 in pregnant rat myometrium (29) . Nevertheless, there is no evidence that excludes OXTR from coupling to other Gi/oα family members. In fact, OXTR has recently been shown to couple to all of the Gi/oα isoforms in transfected HEK293 cells (34) . Expression of Gi/oα isoforms has not been characterized in normal and prostate cancer cell lines. Although Giα1-3 were the predominant Gi/oα family members that were expressed at the mRNA levels in PC3 cells, Giα2 was most abundant isoform which wasdetected at the protein level in this cell line. Trace amounts of Giα3 protein were detected in the membrane fraction while Gia1 protein was completely absent in these cells. This finding cannot be explained by differential regulation of Giα1-3 mRNAs because Giα2 mRNA was expressed at the lowest level among the three Giα isoforms in PC3 cells. Another possibility is that there might be mutations to cause codon shift in the coding regions of Giα1 and Giα3 genes. However, this proved not to be the case because wild type Giα1 and Giα3 genes were identified in PC3 cells. Therefore, both Giα1 and Giα3 could be diminished in PC3 cells by an unknown posttranscriptional mechanism, which will be studied in the future. In accordance with the present finding, Giα3 protein has been shown to be diminished in primary prostate cancer specimens (35) . Ectopic expression of the Giα2-C352G mutant reversed the inhibition by PTx of OXTinduced cell migration in the transfected PC3 cells, suggesting that OXTR couples to Giα2 that may mediate the OXT-induced migration of PC3 cells. To investigate whether the endogenous Giα2 was involved in the OXTR-regulated PC3 cell migration, we employed a specific siRNA to silence expression of Giα2 gene. The Giα2-targeting siRNA eliminated the Giα2 mRNA by 96%, but did not alter Giα1 and Giα3 mRNA levels in PC3 cells. A 93% reduction in Giα2 mRNA was also observed in DU145 cells that were treated with the Giα2-targeting siRNA. These data indicate that the Giα2-targeting siRNA is very effective in knocking down expression of Giα2 to play important roles in EGF-induced cell migration (36, 37) . However, our study has provided the first line of evidence supporting a similar role of Giα2 in EGF function. Giα2 plays a specific role, because the Giα2-targeting siRNA was no longer effective to block the EGFinduced cell migration in the PC3 cell line that expresses a siRNA-resistant Giα2 gene. Despite the fact that there is no comprehensive picture about how Giα2 is integrated in the EGF signaling, Giα2 appears to play an essential role in prostate cancer cell migration in response to EGF. Our knockdown studies also indicate that the trace amounts of Giα3 protein are unable to rescue oxytocin or EGF-induced cell migration in the absence of Giα2 protein.
In summary, the present study has provided direct evidence that support the expression of OXTR in prostate cancer cell lines. OXT treatment has been shown to activate the Gi/oα-dependent signaling. Giα2 is the most abundant member of the Gi/oα family that is detected at the protein level in PC3 cells. Endogenous Giα2 is required for OXT-as well as EGF-induced cell migration in prostate cancer cells. These data suggest that Giα2 plays an essential role in prostate cancer cell migration. These effects of OXT and EGF were completely eliminated in the PC3 cells that were treated with the Giα2-targeting siRNA. Total cell lysates from PC3 cells were harvested after siRNA transfection followed by Western blot analysis with Giα2 antibody. β-actin was detected as a sample loading control. Data were summarized as Mean ± SEM (n=5) and analyzed by ANOVA and Duncan's modified range tests. Significant differences between groups in a given category 
